James L. Wade

Also affiliated with Cancer Care Specialists of Illinois, Decatur Memorial Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

1.9Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002973

Top 11%

1.9DataRank

Top 11%47 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Papers

Driven by 18 papers — median percentile 0. Top paper: “Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial”.

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Annals of Oncology(2020)10.1016/j.annonc.2020.05.012

N/A

3.1DataRank · unranked

106 citations

Sara A. Hurvitz, Jack A. Di Palma, Ron Bose, A. Jo Chien, Nicholas Iannotti +48 more

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002973

Top 11%

1.9DataRank

Top 11%47 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

Journal of Clinical Oncology(2024)10.1200/jco.23.01100

N/A

0.648DataRank · unranked

21 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Cancer Medicine(2020)10.1002/cam4.3416

N/A

0.523DataRank · unranked

9 citations

Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg +10 more

Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.137

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9623

Top 100%

0DataRank

Top 100%0 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab210

N/A

0DataRank · unranked

70 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO–Friends of Cancer Research Prior Therapies Work Group

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3854

N/A

0DataRank · unranked

31 citations

Diana Merino Vega, Lola A. Fashoyin‐Aje, Suparna Wedam, Gwynn Ison, Sol Atienza +9 more

Immunologic predictors of therapeutic response to neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma (PDA) in SWOG S1505.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.419

N/A

0DataRank · unranked

2 citations

Mai T. Duong, Renee B. Chang, Yuqing Xue, Devora Delman, Ignacio Garrido‐Laguna +15 more

Body composition measurements and overall survival in patients with resectable pancreatic adenocarcinoma receiving neoadjuvant chemotherapy: Analysis from SWOG S1505.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4131

N/A

0DataRank · unranked

0 citations

Mai T. Duong, Robert D. Boutin, Leon Lenchik, Jiyoon Kim, Namita Gandhi +11 more

Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad078

N/A

0DataRank · unranked

20 citations

Hanna Bandos, Priya Rastogi, Barry C. Lembersky, Jong‐Hyeon Jeong, Charles E. Geyer +11 more

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12004

N/A

0DataRank · unranked

7 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1

Top 100%

0DataRank

Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma

Gastroenterology(2024)10.1053/j.gastro.2024.01.013

N/A

0DataRank · unranked

18 citations

Sarah Colby, Ignacio Garrido‐Laguna, Yuqing Xue, Renee B. Chang, Devora Delman +14 more

Importance of information-seeking styles among patients with cancer pre- and post-treatment: A URCC NCORP Research Base study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.1527

N/A

0DataRank · unranked

1 citations

Supriya G. Mohile, David Adler, Ronald M. Epstein, Kah Poh Loh, Annette Medina‐Walpole +15 more

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4504

N/A

0DataRank · unranked

115 citations

Mai T. Duong, Syed A. Ahmad, Namita Gandhi, Muhammad Shaalan Beg, Andrea Wang‐Gillam +7 more

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7010

N/A

0DataRank · unranked

9 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

James L. Wade

Indexed papers

Top data-sharing exemplar

Papers